Anthony Weston, newly appointed CEO of SUANNUTRA, takes the helm to steer global expansion in the nutraceutical market.
In an era where health and wellness are prioritized, the nutraceutical industry has become a focal point of innovation and development. SUANNUTRA, a subsidiary of SUANFARMA, has appointed Anthony Weston as its CEO, a move that is poised to intensify its focus on customer-oriented strategies and global growth.
One of the significant assets of SUANNUTRA lies in its triumvirate of core brands, namely Gonmisol, Monteloeder, and Suanfarma USA. These brands will be at the forefront as SUANNUTRA chases market-leading growth in branded and innovative ingredients. Additionally, SUANNUTRA’s track record in quality and innovation will further cement its position in the market for functional and essential ingredients.
With customers in 50 countries and an impressive network in Europe, USA, and Asia, SUANNUTRA is undoubtedly a global powerhouse. Anthony Weston’s induction as the CEO is set to take this presence a notch higher. His background in global business management and leadership is a treasure trove of expertise that SUANNUTRA plans to exploit.
